Literature DB >> 1325307

A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human sera.

R Verheijen1, B A de Jong, W J van Venrooij.   

Abstract

An ELISA for the detection of anti-topoisomerase I autoantibodies in sera from patients with suspected or manifest rheumatic diseases is described. The antigen source used in this assay consists of a recombinant protein containing the last 695 C-terminal amino acid residues of human topoisomerase I (topo I). The sensitivity of the assay was 61%, while the specificity was more than 98%. Using this ELISA, 47 sera from scleroderma patients and immunopositive for anti-topo I antibodies, were screened for the presence of the isotypes IgG, IgA and IgM to topo I. Our finding that relatively high levels of IgA antibodies to topo I are present in most of the sera tested is consistent with the results of Hildebrandt et al. [1]. In addition, it is demonstrated that the IgG and IgA antibodies in a serum may recognize different epitope regions on the topo I polypeptide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325307      PMCID: PMC1554469          DOI: 10.1111/j.1365-2249.1992.tb06980.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

2.  The IgG, IgM, and IgA isotypes of anti-topoisomerase I and anticentromere autoantibodies.

Authors:  S Hildebrandt; E Weiner; J L Senécal; S Noell; L Daniels; W C Earnshaw; N F Rothfield
Journal:  Arthritis Rheum       Date:  1990-05

3.  The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens. Clinical and serological associations in rheumatic diseases.

Authors:  D J de Rooij; L B van de Putte; W J Habets; A L Verbeek; W J van Venrooij
Journal:  Scand J Rheumatol       Date:  1988       Impact factor: 3.641

4.  Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I.

Authors:  H H Guldner; C Szostecki; H P Vosberg; H J Lakomek; E Penner; F A Bautz
Journal:  Chromosoma       Date:  1986       Impact factor: 4.316

Review 5.  Early detection of connective tissue disease in patients with Raynaud's phenomenon.

Authors:  C G Kallenberg
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

Review 6.  Vascular disease in scleroderma. Endothelial T lymphocyte-fibroblast interactions.

Authors:  M B Kahaleh
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

Review 7.  Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).

Authors:  G Reimer
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

8.  Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis.

Authors:  G G Maul; S A Jimenez; E Riggs; D Ziemnicka-Kotula
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

9.  The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon.

Authors:  H Wollersheim; T Thien; M H Hoet; W J Van Venrooy
Journal:  Eur J Clin Invest       Date:  1989-12       Impact factor: 4.686

10.  Molecular cloning of a major CENP-B epitope and its use for the detection of anticentromere autoantibodies.

Authors:  R Verheijen; B A de Jong; E H Oberyé; W J van Venrooij
Journal:  Mol Biol Rep       Date:  1992-02       Impact factor: 2.316

View more
  4 in total

1.  IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis.

Authors:  Erasmo Martínez-Cordero; Alejandro Padilla Trejo; Diana E Aguilar León
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

2.  Localization of autoepitopes on the PCM-1 autoantigen using scleroderma sera with autoantibodies against the centrosome.

Authors:  L Bao; C E Varden; W E Zimmer; R Balczon
Journal:  Mol Biol Rep       Date:  1998-03       Impact factor: 2.316

3.  Detection of anti-topoisomerase I antibodies using a full length human topoisomerase I recombinant protein purified from a baculovirus expression system.

Authors:  J Whyte; W C Earnshaw; J J Champoux; L H Parker; L Stewart; N D Hall; N J McHugh
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

4.  Association of Anti-Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti-Topoisomerase I-Positive Systemic Sclerosis.

Authors:  Maaike Boonstra; Jaap A Bakker; Annette Grummels; Maarten K Ninaber; Nina Ajmone Marsan; Corrie M Wortel; Tom W J Huizinga; Suzana Jordan; Anna-Maria Hoffman-Vold; Oliver Distler; René E M Toes; Hans Ulrich Scherer; Jeska K de Vries-Bouwstra
Journal:  Arthritis Rheumatol       Date:  2020-09-29       Impact factor: 10.995

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.